Properties (49)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
chemical compound
|
| gptkbp:application |
used in pharmaceutical research
|
| gptkbp:built |
limited solubility in water
|
| gptkbp:campusFacilities |
developed_by_XYZ_University
|
| gptkbp:chemicalFormula |
white crystalline solid
reacts with nucleophiles stable under normal conditions thiazole derivatives contains thiazole rings C12H14N2O3S |
| gptkbp:clinicalTrials |
Phase II trials ongoing
investigated for leukemia treatment |
| gptkbp:collaborations |
gptkb:ABC_Pharmaceuticals
collaborated_with_DEF_Institute |
| gptkbp:compatibleWith |
moderate bioavailability
exhibits anti-cancer properties |
| gptkbp:competitors |
high market potential in oncology
|
| gptkbp:composedOf |
via multi-step organic synthesis
|
| gptkbp:dissolved |
soluble in DMSO
|
| gptkbp:environmentalImpact |
low toxicity in animal models
|
| gptkbp:fauna |
tested in mouse models
|
| gptkbp:funding |
funded_by_National_Institutes_of_Health
|
| gptkbp:future_plans |
exploration of combination therapies
|
| https://www.w3.org/2000/01/rdf-schema#label |
WPC-332
|
| gptkbp:impact |
mild nausea reported
|
| gptkbp:influenced |
synergistic with other drugs
|
| gptkbp:is_aimed_at |
various cancers
|
| gptkbp:isATypeOf |
123456-78-9
|
| gptkbp:judgingCriteria |
HPLC_used_for_purity_analysis
|
| gptkbp:market |
not commercially available yet
|
| gptkbp:notableWork |
significant impact on cancer research.
|
| gptkbp:nutritionalValue |
metabolized in liver
|
| gptkbp:origin |
N-(4-(2-(4-(methylthio)phenyl)thiazol-4-yl)thiazol-2-yl)phenyl)acetamide
|
| gptkbp:patentAssignee |
gptkb:XYZ_University
|
| gptkbp:patentStatus |
patented compound
|
| gptkbp:publications |
multiple papers published
|
| gptkbp:regulatoryCompliance |
under_review_by_FDA
|
| gptkbp:related_to |
similar to WPC-331
|
| gptkbp:releaseYear |
2010
|
| gptkbp:research |
investigated in clinical trials
|
| gptkbp:route |
oral administration
|
| gptkbp:safety |
handle with care, wear gloves
|
| gptkbp:safety_features |
favorable safety profile
|
| gptkbp:safetyFeatures |
available upon request
|
| gptkbp:storage |
store_at_-20°C
|
| gptkbp:targets |
inhibitor of certain kinases
|
| gptkbp:triggerType |
inhibits cell proliferation
|
| gptkbp:waterManagement |
excreted via urine
|
| gptkbp:weight |
270.32 g/mol
|